Search

Your search keyword '"Paitoonpong, Leilani"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Paitoonpong, Leilani" Remove constraint Author: "Paitoonpong, Leilani"
44 results on '"Paitoonpong, Leilani"'

Search Results

2. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery

3. Comparative Performance in the Detection of Four Coronavirus Genera from Human, Animal, and Environmental Specimens

5. Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen

6. High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand

8. High transmission rates of early omicron sub-variant BA.2 in Bangkok, Thailand

9. SARS-CoV-2 Variants Detection Strategies in Wastewater Samples Collected in the Bangkok Metropolitan Region

10. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery

11. Benefits of switching mycophenolic acid to sirolimus on serological response after a SARS-CoV-2 booster dose among kidney transplant recipients: a randomized controlled trial

13. Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study

14. The Predictors for Severe SARS-CoV-2 Omicron (B.1.1.529) and Pre-Omicron Variants Infection Among Kidney Transplant Recipients

17. Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

20. Multiple clades of SARS‐CoV‐2 were introduced to Thailand during the first quarter of 2020

21. Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers

22. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.

26. Multimodality treatment in immunocompromised patients with severe COVID ‐19: the role of IL ‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion

27. U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific Rim

29. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand

30. Evaluating the efficiency of specimen pooling for PCR‐based detection of COVID‐19

32. A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient

33. Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19

34. SARS-CoV-2 Pandemic Response, Clinical Characteristics and Outcomes at Bangkok's Largest Emerging Diseases Clinical Centre

35. Bilateral Adrenal Histoplasmosis

36. A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient.

37. Sa1041 PERFORMANCE CHARACTERISTICS AND OPTIMAL CUT-OFF VALUE OF ADENOSINE TRIPHOSPHATE TESTING FOR RAPID EVALUATION OF BACTERIAL CONTAMINATION AFTER REPROCESSING DUODENOSCOPES

40. Adult pertussis is unrecognized public health problem in Thailand.

42. Adult pertussis is unrecognized public health problem in Thailand.

43. Bartonella henselae: first reported isolate in a human in Thailand.

44. Brucellosis: the first case of King Chulalongkorn Memorial Hospital and review of the literature.

Catalog

Books, media, physical & digital resources